US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,815.87

+24.100.86%

Number of Gainers:1

Number of Losers:4

Number of Flat:- -

PE:- -

High:2,853.25

Open:2,793.48

Low:2,766.53

Close:2,793.52

Volume:2.42M

Turnover:59.73M

Market Cap:46.97B

Float Cap:43.85B

Loading ...

Teva Releases Q3 2026 Aide Memoire

THOMSON REUTERS

Evofem Contracts Second Manufacturer for Phexxi Contraceptive Gel

Evofem Biosciences Adds Additional Manufacturing Capacity for Phexx® to Support Global Growth Strategy

THOMSON REUTERS

Evofem Biosciences - Additional Manufacturing Source Expected to Reduce Unit Costs by 40% or More

THOMSON REUTERS

Evofem Biosciences - to Submit Snda to FDA for Phexx in Mid-2027

THOMSON REUTERS

Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says

MT Newswires Live

Top Teva Insider Makes Massive Multi-Million Dollar Stock Move

NYSE Order Imbalance 52798.0 Shares on Buy Side

THOMSON REUTERS

Teva presents new new real-world data on uzedy at Psych Congress

Teva Highlights New Real-World Data Showing Uzedy® (Risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

THOMSON REUTERS

Teva Pharmaceutical Announces New Senior Notes Offering

Femasys announces Minnesota Women’s Care to implement FemVue

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care

Teva Pharmaceutical Begins Direct Trading of Shares on NYSE

MT Newswires Live

Daré Bioscience Reports Phase 1 Study Shows Topical Sildenafil Cream Cuts Systemic Exposure Versus Oral Dose

Teva Pharmaceutical Announces Major Senior Notes Financing

Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power

MannKind management to meet with Cantor

Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2817.6208,"timestamp":1790262070681,"preClose":2793.5195,"halted":0,"volume":2420449,"delay":0,"changeRate":0.008628,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":24.101318,"latestTime":"09-24 11:01:10 EDT","open":2793.4788,"high":2853.2537,"low":2766.5264,"amount":59733658.05272,"amplitude":0.031046,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790280000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.122556,"peRate":75.479338,"turnoverRate":0.001685,"increases":1,"decrements":4,"flats":0,"marketCap":46972862776,"floatMarketCap":43854643212},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2853.2537,"amplitude":0.031046,"preClose":2793.5195,"low":2766.5264,"pbRate":"6.122556","latestPrice":2815.8748,"volume":2420339,"delay":0,"open":2793.4788,"prevYearClose":2379.9924,"prevWeekClose":2796.6025,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2809.1672,"twentyDayClose":2852.123,"sixtyDayClose":2562.5076,"secType":"PLATE","market":"US","turnoverRate":0.001685,"peRate":75.479338,"marketCap":46972862776,"floatMarketCap":43854643212,"timestamp":1790262065785,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":1,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669095436","title":"Teva Releases Q3 2026 Aide Memoire","url":"https://stock-news.laohu8.com/highlight/detail?id=2669095436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669095436?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:45","pubTimestamp":1790196300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABKND6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4584","BK4596","LU2324357040.USD","TEVA","BK4588","BK4585","BK4007","BK4566","LU1983299246.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436369","title":"Evofem Contracts Second Manufacturer for Phexxi Contraceptive Gel","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436369","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436369?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:07","pubTimestamp":1790194021,"startTime":"0","endTime":"0","summary":"Evofem contracts second manufacturer for Phexxi contraceptive gelEvofem Biosciences contracted a second pharmaceutical manufacturer to produce its PHEXX prescription contraceptive vaginal gel, expandi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL1D159v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVFM","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436895","title":"Evofem Biosciences Adds Additional Manufacturing Capacity for Phexx® to Support Global Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436895?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVFM","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436800","title":"Evofem Biosciences - Additional Manufacturing Source Expected to Reduce Unit Costs by 40% or More","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436800","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436800?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EVFM","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669243680","title":"Evofem Biosciences - to Submit Snda to FDA for Phexx in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669243680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669243680?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0YB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4584","EVFM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480359","title":"Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480359","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:13","pubTimestamp":1790180005,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical (TEVA) is entering a strong growth phase despite near-term concerns around Austedo and gRevlimid, Oppenheimer said in a note Wednesday.The analysts said the company is entering the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","BK4584","BK4007","BK4596","LU1983299246.USD","BK4585","TEVA","BK4559","LU2324357040.USD","BK4557","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669792051","title":"Top Teva Insider Makes Massive Multi-Million Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2669792051","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669792051?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:03","pubTimestamp":1790128985,"startTime":"0","endTime":"0","summary":"New insider activity at Teva Pharmaceutical ( ($TEVA) ) has taken place on September 22, 2026. Teva Pharmaceutical has seen a notable insider move ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-teva-insider-makes-massive-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-teva-insider-makes-massive-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4557","BK4588","LU2324357040.USD","TEVA","BK4007","BK4559","BK4584","BK4585","BK4596","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669327198","title":"NYSE Order Imbalance 52798.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2669327198","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669327198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:50","pubTimestamp":1790020203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nAQN2MK64P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4584","BK4557","LU1983299246.USD","LU2324357040.USD","BK4559","BK4585","BK4596","BK4588","TEVA","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668758919","title":"Teva presents new new real-world data on uzedy at Psych Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2668758919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668758919?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:50","pubTimestamp":1789764616,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals announced new real-world data evaluating treatment continuity, healthcare resource utilization and clinical outcomes am...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-presents-new-new-real-world-data-on-uzedy-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-presents-new-new-real-world-data-on-uzedy-at-psych-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","LU2324357040.USD","BK4007","NOBL","LU1983299246.USD","BK4588","VHT","BK4585","CGCV","IXJ","BK4596","BK4584","BK4559","TEVA","BK4566","BK4557","TCAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987973","title":"Teva Highlights New Real-World Data Showing Uzedy® (Risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:31","pubTimestamp":1789763460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA9WVSCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4566","BK4596","LU1983299246.USD","BK4585","BK4559","BK4007","BK4557","BK4584","TEVA","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668702935","title":"Teva Pharmaceutical Announces New Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2668702935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668702935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:49","pubTimestamp":1789591748,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical ( ($TEVA) ) has issued an update. On September 16, 2026, Teva’s Dutch finance units issued €1.5 billion of senior euro notes an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4557","BK4588","LU2324357040.USD","TEVA","BK4007","BK4559","BK4584","BK4585","BK4596","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630640","title":"Femasys announces Minnesota Women’s Care to implement FemVue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630640","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630640?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:20","pubTimestamp":1789478419,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that Minnesota Women’s Care will implement FemVue for fertility diagnostic evaluation and FemaSeed Complete for in-office ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-minnesota-womens-care-to-implement-femvue-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-minnesota-womens-care-to-implement-femvue-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEMY","BK4082","BK4584","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667864058","title":"Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2667864058","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667864058?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:00","pubTimestamp":1789477200,"startTime":"0","endTime":"0","summary":"-- Leading multi-site OB/GYN health practice to implement FemVue for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept.  15, 2026 (GLOBE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362177/0/en/femasys-advances-ob-gyn-expansion-with-adoption-of-femaseed-fertility-portfolio-by-minnesota-women-s-care.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4539","BK4584","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693316","title":"Teva Pharmaceutical Begins Direct Trading of Shares on NYSE","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693316?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:02","pubTimestamp":1789390972,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  ordinary shares began trading directly on the New York Stock Exchange, completing its transition from its American depositary shares program, the drugmaker said Monday.The company said the shares will continue to trade under the ticker \"TEVA\" on both the NYSE and Tel Aviv Stock Exchange.Teva said the direct listing is expected to expand investor access and strengthen its position in US capital markets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU1983299246.USD","BK4559","BK4007","LU2324357040.USD","BK4585","TEVA","BK4596","BK4557","BK4566","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664326","title":"Daré Bioscience Reports Phase 1 Study Shows Topical Sildenafil Cream Cuts Systemic Exposure Versus Oral Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664326","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664326?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:50","pubTimestamp":1789390221,"startTime":"0","endTime":"0","summary":"Daré Bioscience reports Phase 1 study shows topical sildenafil cream cuts systemic exposure versus oral doseDaré Bioscience reported peer-reviewed publication of Phase 1 results for topical Sildenafil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL761hnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4007","BK4584","BK4112","IE00BQXX3F31.USD","LU2210150020.SGD","DARE","SG9999014013.SGD","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3D17.EUR","BCDF","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4588","IE00BQXX3C00.GBP","BK4585","IE00B3QW5Z07.USD","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666734574","title":"Teva Pharmaceutical Announces Major Senior Notes Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666734574","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666734574?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158804,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical ( ($TEVA) ) has shared an announcement. On September 10, 2026, Teva announced it had successfully priced approximately $4.9 bil...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4557","BK4566","BK4584","BK4596","BK4559","BK4585","BK4588","LU1983299246.USD","LU2324357040.USD","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574383","title":"Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574383?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:30","pubTimestamp":1789158651,"startTime":"0","endTime":"0","summary":"Daré Bioscience lowers stockholder meeting quorum requirement to one-third voting powerDaré Bioscience cut the stockholder-meeting quorum threshold to at least one-third of voting power from a majorit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7Dhh6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4584","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666711195","title":"MannKind management to meet with Cantor","url":"https://stock-news.laohu8.com/highlight/detail?id=2666711195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666711195?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:55","pubTimestamp":1789156512,"startTime":"0","endTime":"0","summary":"Meeting to be held in Boston on September 17 hosted by Cantor. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MNKD","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666526782","title":"Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666526782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666526782?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:55","pubTimestamp":1789124124,"startTime":"0","endTime":"0","summary":"Daré Bioscience posts H.C. Wainwright investor conference presentation for on-demand viewingDaré Bioscience posted an on-demand investor presentation for the H.C. Wainwright 28th Annual Global Investm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL58yrZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BN0W2W23.USD","BK4585","IE00BKPKM429.USD","NDAQ","BK4584","BK4112","IE00BQXX3D17.EUR","BK4588","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","SG9999014005.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014039.USD","LU2210149790.SGD","BK4007","DARE","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","LU2095319765.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666627275","title":"Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666627275","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666627275?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:04","pubTimestamp":1789034640,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359281/0/en/teva-announces-successful-pricing-of-4-9-billion-equivalent-senior-notes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","BK4156","BK4559","BK4596","LU2324357040.USD","BK4584","BK4588","BK4007","LU1983299246.USD","BK4557","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}